<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"><html xmlns="http://www.w3.org/1999/xhtml"><head><title></title><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta http-equiv="Content-Language" content="en-US" /><meta http-equiv="Content-Script-Type" content="text/javascript" /><meta http-equiv="Content-Style-Type" content="text/css" /><meta http-equiv="imagetoolbar" content="no" /><meta name="keywords" content="allergan, inamed, agn, pharma, fillers, breast implants, dry eye, glaucoma, obesity, urologics, optive, refresh, restasis, alphagan, combigan, lumigan, acular, alocril, botox, elestat, pred forte, zymar, lap band, lapband, natrelle, captique, cosmoderm, hylaform, juvederm, zyderm, md forte, prevage, vivite, azelex, tazorac, fluoroplex, avage, sanctura" lang="en-US" /><meta name="description" content="Allergan, Inc. is a multi-specialty health care company focused on discovering developing and commercializing innovative pharmaceuticals biologics and medical devices that enable people to live life to its greatest potential" lang="en-US" /><meta name="copyright" content="Allergan" lang="en-US" /><meta name="generator" content="PINT [ www.pint.com ]" lang="en-US" /><meta name="author" content="PINT [ www.pint.com ]" lang="en-US" /><link rel="stylesheet" href="/assets/css/global/common.css" type="text/css" media="screen" /><link rel='stylesheet' href='/assets/css/US/common.css' type='text/css' media='screen' /><link rel="stylesheet" href="/assets/css/global/print.css" type="text/css" media="print" /><!--[if lt IE 7]><link rel="stylesheet" href="/assets/css/global/substandard.css" type="text/css" media="screen" /><![endif]--><script src="/assets/scripts/global/build/yahoo/yahoo.js" type="text/javascript"></script><script src="/assets/scripts/global/build/event/event.js" type="text/javascript"></script><script src="/assets/scripts/global/build/dom/dom.js" type="text/javascript"></script><script src="/assets/scripts/global/build/animation/animation.js" type="text/javascript"></script><script src="/assets/scripts/global/common.js" type="text/javascript"></script><script src="/assets/scripts/global/init.js" type="text/javascript"></script><script language="Javascript" src="/assets/scripts/usa/s_jcode.js"></script>  <script language="Javascript">    <!--    /* You may give each page an identifying name, server, and channel on    the next lines. */     s.pageName="Responsibility: Political Contributions"  s.server=""  s.channel="Responsibility"  s.pageType="Company"  s.prop1=""  s.prop2=""  s.prop3=""  s.prop4=""  s.prop5=""  /* Conversion Variables */  s.campaign=""  s.state=""  s.zip=""  s.events=""  s.products=""  s.purchaseID=""  s.eVar1=""  s.eVar2=""  s.eVar3=""  s.eVar4=""  s.eVar5=""/************* DO NOT ALTER ANYTHING BELOW THIS LINE ! **************/var s_code=s.t();if(s_code)document.write(s_code);//--></script><noscript><a href="http://www.omniture.com" title="Web Analytics"><img height="1" width="1" border="0" alt="" src="http://algusa2007.112.2O7.net/b/ss/algusa2007/1/H.12--NS/0" /></a></noscript></head><body><form name="aspnetForm" method="post" action="/responsibility/political_contributions.htm" id="aspnetForm"><div><input type="hidden" name="MSO_PageHashCode" id="MSO_PageHashCode" value="3" /><input type="hidden" name="__VIEWSTATE" id="__VIEWSTATE" value="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" /></div><a id="top"></a><p id="skip"><a href="#content">Skip to content</a></p><iframe id="shim" style="display:none;filter:progid:DXImageTransform.Microsoft.Chroma(Color='#ffffff');" frameBorder = "0" scrolling="no"></iframe><div id="container">		<div id="header">			   <a href="/index.html"><img src="/assets/images/global/logo_allergan.gif" width="245" height="75" alt="Allergan" /></a><ul id="btn_locations"><li><a href="/about/global/index.html">Global Locations<strong> </strong></a></li></ul><ul id="btn_contact"><li><a href="/contact/index.html">Contact Us<strong> </strong></a></li></ul><table cellpadding="0" cellspacing="0" class="headsearch"><tr><td><input type="text" name="query" id="query" class="input" /></td><td><ul id="btn_search"><li><a href="#">Search<strong> </strong></a></li></ul></td></tr></table>		                     <ul id="nav">            <li class='nav_1' onmouseover='ShowShim(this)' onmouseout='HideShim(this)'><a href='/about/index.htm'>About Us<strong>&nbsp;</strong><!--[if IE 7]><!--></a><!--<![endif]--><!--[if lte IE 6]><table cellspacing="0"><tr><td><![endif]-->        <ul>                <li class='1'><a href='/about/history.htm'>History                                      </a>                </li>                            <li class='1'><a href='/about/leadership.htm'>Leadership                                      </a>                </li>                            <li class='1'><a href='/about/mission_values.htm'>Mission and Values                                      </a>                </li>                            <li class='1'><a href='/about/global/index.htm'>Global Locations                                      </a>                </li>                        </ul><!--[if lte IE 6]></td></tr></table></a><![endif]-->                        </li>            <li class='nav_2' onmouseover='ShowShim(this)' onmouseout='HideShim(this)'><a href='/treatments/index.htm'>What We Treat<strong>&nbsp;</strong><!--[if IE 7]><!--></a><!--<![endif]--><!--[if lte IE 6]><table cellspacing="0"><tr><td><![endif]-->        <ul>                <li class='1'><a href='/treatments/eye_care/index.htm'>            Eye Care                                                :<!--[if IE 7]><!--></a><!--<![endif]--><!--[if lte IE 6]><table cellspacing="0"><tr><td><![endif]--><ul><li><a href='/treatments/eye_care/dry_eye.htm'>Dry Eye</a></li><li><a href='/treatments/eye_care/glaucoma.htm'>Glaucoma</a></li><li><a href='/treatments/eye_care/other_eye_conditions.htm'>Other Eye Conditions</a></li></ul><!--[if lte IE 6]></td></tr></table></a><![endif]-->                </li>                            <li class='1'><a href='/treatments/neurosciences/index.htm'>Neurosciences                                      :<!--[if IE 7]><!--></a><!--<![endif]--><!--[if lte IE 6]><table cellspacing="0"><tr><td><![endif]--><ul><li><a href='/treatments/neurosciences/blepharospasm.htm'>Blepharospasm</a></li><li><a href='/treatments/neurosciences/cervical_dystonia.htm'>Cervical Dystonia</a></li><li><a href='/treatments/neurosciences/chronic_migraine.htm'>Chronic Migraine</a></li><li><a href='/treatments/neurosciences/strabismus.htm'>Strabismus</a></li><li><a href='/treatments/neurosciences/uls.htm'>Upper Limb Spasticity</a></li></ul><!--[if lte IE 6]></td></tr></table></a><![endif]-->                </li>                            <li class='1'><a href='/treatments/medical_aesthetics/index.htm'>Medical Aesthetics                                      :<!--[if IE 7]><!--></a><!--<![endif]--><!--[if lte IE 6]><table cellspacing="0"><tr><td><![endif]--><ul><li><a href='/treatments/medical_aesthetics/breast_aesthetics.htm'>Breast Aesthetics</a></li><li><a href='/treatments/medical_aesthetics/facial_aesthetics.htm'>Facial Aesthetics</a></li></ul><!--[if lte IE 6]></td></tr></table></a><![endif]-->                </li>                            <li class='1'><a href='/treatments/medical_dermatology/index.htm'>Medical Dermatology                                      :<!--[if IE 7]><!--></a><!--<![endif]--><!--[if lte IE 6]><table cellspacing="0"><tr><td><![endif]--><ul><li><a href='/treatments/medical_dermatology/acne.htm'>Acne</a></li><li><a href='/treatments/medical_dermatology/psoriasis.htm'>Psoriasis</a></li><li><a href='/treatments/medical_dermatology/severe_primary_axillary_hyperhidrosis.htm'>Severe Primary Axillary Hyperhidrosis Inadequately Managed with Topical Agents</a></li><li><a href='/treatments/medical_dermatology/other_skin_conditions.htm'>Other Skin Conditions</a></li></ul><!--[if lte IE 6]></td></tr></table></a><![endif]-->                </li>                            <li class='1'><a href='/treatments/urologics/index.htm'>Urologics                                      :<!--[if IE 7]><!--></a><!--<![endif]--><!--[if lte IE 6]><table cellspacing="0"><tr><td><![endif]--><ul><li><a href='/treatments/urologics/urinary_incontinence.htm'>Urinary Incontinence</a></li><li><a href='/treatments/urologics/overactive_bladder.htm'>Overactive Bladder</a></li></ul><!--[if lte IE 6]></td></tr></table></a><![endif]-->                </li>                        </ul><!--[if lte IE 6]></td></tr></table></a><![endif]-->                        </li>            <li class='nav_3' onmouseover='ShowShim(this)' onmouseout='HideShim(this)'><a href='/products/index.htm'>Products<strong>&nbsp;</strong><!--[if IE 7]><!--></a><!--<![endif]--><!--[if lte IE 6]><table cellspacing="0"><tr><td><![endif]-->        <ul>                <li class='1'><a href='/products/eye_care/index.htm'>Ophthalmic Pharmaceuticals                                      </a>                </li>                            <li class='1'><a href='/products/neurosciences/index.htm'>Neurosciences                                      </a>                </li>                            <li class='1'><a href='/products/medical_aesthetics/index.htm'>Medical Aesthetics: Breast and Facial                                      </a>                </li>                            <li class='1'><a href='/products/medical_dermatology/index.htm'>Medical Dermatology                                      </a>                </li>                            <li class='1'><a href='/products/urologics/index.htm'>Urologics                                      </a>                </li>                            <li class='1'><a href='/products/prescribing_information.htm'>Product Prescribing and Labeling Information                                      </a>                </li>                            <li class='1'><a href='/products/patent_notices.htm'>Patent Notices                                      </a>                </li>                        </ul><!--[if lte IE 6]></td></tr></table></a><![endif]-->                        </li>            <li class='nav_4' onmouseover='ShowShim(this)' onmouseout='HideShim(this)'><a href='/research_and_development/index.htm'>R&D<strong>&nbsp;</strong><!--[if IE 7]><!--></a><!--<![endif]--><!--[if lte IE 6]><table cellspacing="0"><tr><td><![endif]-->        <ul>                <li class='1'><a href='/research_and_development/pipeline.htm'>Pipeline                                      </a>                </li>                            <li class='1'><a href='/research_and_development/allergan_clinical_trials.htm'>Allergan Clinical Trials                                      </a>                </li>                            <li class='1'><a href='/research_and_development/excellence_in_research.htm'>Excellence in Research                                      </a>                </li>                        </ul><!--[if lte IE 6]></td></tr></table></a><![endif]-->                        </li>            <li class='nav_5' onmouseover='ShowShim(this)' onmouseout='HideShim(this)'><a href='/medical_affairs/index.htm'>Medical Affairs<strong>&nbsp;</strong><!--[if IE 7]><!--></a><!--<![endif]--><!--[if lte IE 6]><table cellspacing="0"><tr><td><![endif]-->        <ul>            </ul><!--[if lte IE 6]></td></tr></table></a><![endif]-->                        </li>            <li class='nav_6' onmouseover='ShowShim(this)' onmouseout='HideShim(this)'><a href='/newsroom/index.htm'>Newsroom<strong>&nbsp;</strong><!--[if IE 7]><!--></a><!--<![endif]--><!--[if lte IE 6]><table cellspacing="0"><tr><td><![endif]-->        <ul>                <li class='1'><a href='/newsroom/fast_facts.htm'>Fast Facts                                      </a>                </li>                            <li class='1'><a href='http://agn.client.shareholder.com/releases.cfm'>Press Releases                                      </a>                </li>                        </ul><!--[if lte IE 6]></td></tr></table></a><![endif]-->                        </li>            <li class='nav_7' onmouseover='ShowShim(this)' onmouseout='HideShim(this)'><a href='/investors/index.htm'>Investors<strong>&nbsp;</strong><!--[if IE 7]><!--></a><!--<![endif]--><!--[if lte IE 6]><table cellspacing="0"><tr><td><![endif]-->        <ul>                <li class='1'><a href='http://agn.client.shareholder.com/earnings.cfm'>Earnings Releases                                      </a>                </li>                            <li class='1'><a href='http://agn.client.shareholder.com/stockquote.cfm'>Stock Information                                      </a>                </li>                            <li class='1'><a href='http://agn.client.shareholder.com/financials.cfm'>Financial Reports                                      </a>                </li>                            <li class='1'><a href='/investors/nongaap_financial_reconciliation.htm'>Non-GAAP Financial Reconciliation                                      </a>                </li>                            <li class='1'><a href='/investors/corporate_governance_and_certificates.htm'>Corporate Governance & Certificates                                      </a>                </li>                            <li class='1'><a href='http://agn.client.shareholder.com/events.cfm'>Webcasts & Transcripts                                      </a>                </li>                            <li class='1'><a href='/investors/analyst_coverage.htm'>Analyst Coverage                                      </a>                </li>                            <li class='1'><a href='/investors/shareholder_information.htm'>Shareholder Information                                      </a>                </li>                            <li class='1'><a href='/investors/contact_information.htm'>Contact Information                                      </a>                </li>                        </ul><!--[if lte IE 6]></td></tr></table></a><![endif]-->                        </li>            <li class="nav_8_on" onmouseover='ShowShim(this)' onmouseout='HideShim(this)'><a href='/responsibility/index.htm'>Responsibility<strong>&nbsp;</strong><!--[if IE 7]><!--></a><!--<![endif]--><!--[if lte IE 6]><table cellspacing="0"><tr><td><![endif]-->        <ul>                <li><a href='/responsibility/environmental_health_and_safety.htm'>Corporate Social Responsibility</a>                </li>                            <li><a href='/responsibility/patient_safety/index.htm'>Patient Safety and Product Quality</a>                </li>                            <li><a href='/responsibility/compliance/index.htm'>Compliance and Ethics</a>                </li>                            <li><a href='/responsibility/allergan_foundation.htm'>Allergan Foundation</a>                </li>                            <li><a href='/responsibility/patient_resources/index.htm'>Patient Resources</a>                </li>                            <li><a href='/responsibility/physician_resources.htm'>Physician Resources</a>                </li>                            <li><a href='/responsibility/professional_affiliations.htm'>Professional Affiliations</a>                </li>                            <li><a href='/responsibility/unrestricted_educational_grants.htm'>Unrestricted Educational Grants</a>                </li>                            <li><a href='/responsibility/political_contributions.htm'>Political Contributions</a>                </li>                            <li><a href='/responsibility/ca_supply_chain_disclosure.htm'>California Supply Chain Disclosure</a>                </li>                            <li><a href='/responsibility/hcp_partnership_payments/index.htm'>Health Care Provider Partnerships & Payments</a>                </li>                            <li><a href='/responsibility/human_rights.htm'>Commitment to Human Rights Charters</a>                </li>                            <li><a href='/responsibility/product_safety_and_animal_testing.htm'>Animal Testing</a>                </li>                        </ul><!--[if lte IE 6]></td></tr></table></a><![endif]-->                </li>            <li class='nav_9' onmouseover='ShowShim(this)' onmouseout='HideShim(this)'><a href='/careers/index.htm'>Careers<strong>&nbsp;</strong><!--[if IE 7]><!--></a><!--<![endif]--><!--[if lte IE 6]><table cellspacing="0"><tr><td><![endif]-->        <ul>                <li class='1'><a href='/careers/mission_values.htm'>Mission and Values                                      </a>                </li>                            <li class='1'><a href='/careers/total_rewards.htm'>Total Rewards                                      </a>                </li>                            <li class='1'><a href='/careers/recognizing_excellence.htm'>Recognizing Excellence                                      </a>                </li>                            <li class='1'><a href='/careers/global/index.htm'>Global Careers at Allergan                                      </a>                </li>                            <li class='1'><a href='https://allergan.taleo.net/careersection/external/jobsearch.ftl?location=101372523' target='_blank'>Job Search                                      </a>                </li>                            <li class='1'><a href='https://allergan.taleo.net/careersection/external/profile.ftl' target='_blank'>My Candidate Profile                                      </a>                </li>                            <li class='1'><a href='/careers/faq.html'>FAQ                                      </a>                </li>                        </ul><!--[if lte IE 6]></td></tr></table></a><![endif]-->                        </li>          </ul>	  <span class="hide">-->-->-->--></span>		 	            	</div><!-- END: header -->	    	        <div id="main">                 <div id="subnav">            <h4>In this Section:</h4><ul id="subnavlist">   <li><a href='/responsibility/index.htm'>Overview</a></li>   <li><a href='/responsibility/environmental_health_and_safety.htm'>Corporate Social Responsibility</a></li>   <li><a href='/responsibility/patient_safety/index.htm'>A Note from David E. I. Pyott</a></li>   <li><a href='/responsibility/compliance/index.htm'>Compliance and Ethics</a></li>   <li><a href='/responsibility/allergan_foundation.htm'>Allergan Foundation</a></li>   <li><a href='/responsibility/patient_resources/index.htm'>Patient Resources</a></li>   <li><a href='/responsibility/physician_resources.htm'>Physician Resources</a></li>   <li><a href='/responsibility/professional_affiliations.htm'>Professional Affiliations</a></li>   <li><a href='/responsibility/unrestricted_educational_grants.htm'>Unrestricted Educational Grants</a></li>    <li><p>Political Contributions</p></li>       <li><a href='/responsibility/ca_supply_chain_disclosure.htm'>California Supply Chain Disclosure</a></li>   <li><a href='/responsibility/hcp_partnership_payments/index.htm'>        Health Care Provider Partnerships & Payments      </a></li>   <li><a href='/responsibility/human_rights.htm'>Commitment to Human Rights Charters</a></li>   <li><a href='/responsibility/product_safety_and_animal_testing.htm'>Animal Testing</a></li>    </ul>                </div>	    <div id="content">        <h1>Political Contributions</h1><p>            Allergan recognizes that informed public policy is a critical factor in achieving its goal of pursuing medical advances to help patients live life to their fullest potential. Allergan participates in the political process and supports those policies, candidates and organizations who work to advance healthcare innovation and improve patient access to needed medical treatments while also recognizing that a fair, free market system provides the best atmosphere for continued innovation. While Federal law prohibits corporations from making political contributions to Federal candidates, companies can establish political action committees that are funded solely through voluntary employee contributions. The Allergan Political Action Committee for Employees (APACE) was established to provide eligible employees a direct means to voluntarily participate in shaping sound public policy on issues related to Allergan’s businesses. APACE operates in accordance with all relevant Federal and state laws and supports candidates from both parties. All APACE contributions are publicly disclosed in reports available on the Federal Election Commission’s Web site at <a href="http://www.fec.gov" target="_blank" onmouseout="return HideAlert(this)" onclick="return PromptAlert(this)" onmouseover="return ShowAlert(this)">            www.fec.gov</a>.          </p><p>            Allergan retains independent experts to assist the Company in complying with all applicable election and campaign laws. In certain jurisdictions where it is permitted, Allergan makes corporate contributions to support election campaigns, party committees, and ballot measures. Allergan supports candidates from both parties. Beginning January 1, 2009 and on a semi-annual basis, Allergan makes a list of all corporate state and local political contributions and independent expenditures, if any, supporting or opposing candidates, committees, political parties and ballot measures available via this website.          </p><p>            Allergan is a member of several industry and trade groups that represent both the pharmaceutical and the business community at large in an effort to bring about consensus on broad policy issues that can impact Allergan’s business objectives and ability to help patients live life to their fullest potential. Allergan’s participation as a member of these various industry and trade groups comes with the understanding that we may not always agree with the positions of the larger organization and/or other members, and we are committed to voicing our concerns as appropriate through our colleagues who serve on the boards and committees of these groups. Click <a href="/assets/pdf/allergan_memberships.pdf" target="_blank">here</a> for a partial listing of our current memberships.          </p><p>            Allergan has a code of business conduct and ethics that discourages employees from using corporate funds or assets for political purposes unless approved by the Company’s Government Affairs Department, Legal Department or Compliance Department. Further, the Corporate Governance and Compliance Committee of Allergan’s Board of Directors, which is comprised entirely of independent directors, annually reviews Allergan’s political contributions, as well as its contribution policies and practices. In addition, APACE’s board, which is generally comprised of employees who are APACE participants, also assists Allergan's Government Affairs Department in selecting policies, candidates and organizations to support. When selecting candidates for funding, priority is given to candidates’ views on issues that concern Allergan’s businesses and the presence of employees or facilities in such candidate’s state or district.          </p><p>            Questions regarding Allergan’s political contributions, or how to become more involved in the policies that affect Allergan, should be directed to Allergan’s Government Affairs Department. Questions regarding APACE should be directed to: Treasurer, Allergan Political Action Committee for Employees, 2148 E. Orangeview Lane, Orange, CA 92867.          </p><h5><a class="arrow" href="/assets/pdf/political_contributions_2013-2.pdf">Allergan Corporate Contributions Second Half 2013<span> </span></a></h5><h5><a class="arrow" href="/assets/pdf/political_contributions_2013-1.pdf">Allergan Corporate Contributions First Half 2013<span> </span></a></h5><h5><a class="arrow" href="/assets/pdf/political_contributions_2012-2.pdf">Allergan Corporate Contributions Second Half 2012<span> </span></a></h5><h5><a class="arrow" href="/assets/pdf/political_contributions_2012-1.pdf">Allergan Corporate Contributions First Half 2012<span> </span></a></h5><h5><a class="arrow" href="/assets/pdf/political_contributions_2011-2.pdf">Allergan Corporate Contributions Second Half 2011<span> </span></a></h5><h5><a class="arrow" href="/assets/pdf/political_contributions_2011-1.pdf">Allergan Corporate Contributions First Half 2011<span> </span></a></h5><h5><a class="arrow" href="/assets/pdf/political_contributions_2010-2.pdf">Allergan Corporate Contributions Second Half 2010<span> </span></a></h5><h5><a class="arrow" href="/assets/pdf/political_contributions_2010-1.pdf">Allergan Corporate Contributions First Half 2010<span> </span></a></h5><h5><a class="arrow" href="/assets/pdf/political_contributions_2009-2.pdf">Allergan Corporate Contributions Second Half 2009<span> </span></a></h5><h5><a class="arrow" href="/assets/pdf/political_contributions_2009-1.pdf">Allergan Corporate Contributions First Half 2009<span> </span></a></h5><div id="twitter"><br /><p><a href="http://twitter.com/Allergan" target="_blank">          Follow Allergan, Inc. on:           <img src="/assets/images/global/twitter_icon.png" width="20" height="20" class="mid" alt="Follow on Twitter" /></a></p></div>        <br class="clear" />    </div><!-- END: content -->    	            <br class="clear" />    </div><!-- END: main -->                <div id="footer"><p>                   © 2014 Allergan, Inc. All Rights Reserved.                                   <a href="/index.html">Home</a>      |      <a href="/sitemap/index.html">Site Map</a>      |            <a href="/privacy_and_terms/index.html">PRIVACY POLICY AND TERMS OF USE</a><br />Information posted to this Web site is intended for U.S. residents. Please visit the local Allergan Web site for your country for information concerning Allergan products and services available in your country of residence.            </p></div>      	</div><!-- END: container --></form></body></html>